KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Long-Term Investments (2020)

GoodRx Holdings (GDRX) has disclosed Long-Term Investments for 1 consecutive years, with $711.4 million as the latest value for Q4 2020.

  • Quarterly Long-Term Investments changed N/A to $711.4 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $711.4 million through Dec 2020, changed N/A year-over-year, with the annual reading at $711.4 million for FY2020, N/A changed from the prior year.
  • Long-Term Investments hit $711.4 million in Q4 2020 for GoodRx Holdings.
  • In the past five years, Long-Term Investments ranged from a high of $711.4 million in Q4 2020 to a low of $711.4 million in Q4 2020.